Physical Activity Readiness Questionnaire

1. Abstract

The Physical Activity Readiness Questionnaire (PAR-Q) is an internationally recognized, evidence-based self-screening instrument engineered to identify individuals for whom an increase in physical activity or participation in structured exercise may present an elevated risk of acute adverse cardiovascular or musculoskeletal events. Developed originally by the British Columbia Department of Health and subsequently refined by the Canadian Society for Exercise Physiology (CSEP) and the American College of Sports Medicine (ACSM), the PAR-Q functions as a minimal pre-exercise screening tool for adults aged 15 to 69 years. The instrument operationalizes pre-exercise clinical readiness across a unidimensional risk-stratification architecture consisting of 7 dichotomous (Yes/No) items probing cardiopulmonary symptoms (e.g., exertional and non-exertional chest discomfort), central nervous system stability (syncope and dizziness-induced balance deficits), structural musculoskeletal contraindications (aggravation of bone or joint disorders), and concurrent pharmacotherapy for cardiovascular disease.

Psychometrically, the PAR-Q demonstrates high clinical sensitivity (ranging from 89% to 100% in detecting moderate-to-severe absolute or relative exercise contraindications) paired with moderate specificity (ranging between 42% and 80%, depending on cohort age and clinical morbidity). Test-retest reliability across short administration windows demonstrates substantial stability (Cohen’s κ = 0.78–0.92). Any single affirmative response triggers a risk-mitigation pathway mandating medical clearance and tailored exercise prescription prior to functional assessment or physical exertion. This comprehensive review synthesizes the construct morphology, theoretical underpinnings in cardiovascular epidemiology and behavioral readiness, psychometric properties, structural factor mechanics, administration protocols, and complete authentic scale contents of the PAR-Q.

2. Keywords

Physical Activity Readiness Questionnaire, PAR-Q, pre-exercise screening, exercise safety, risk stratification, clinical psychometrics, cardiovascular contraindications, exercise readiness, health appraisal, Canadian Society for Exercise Physiology

3. Authors

The original conceptualization and empirical development of the Physical Activity Readiness Questionnaire was spearheaded in the 1970s by researchers associated with the British Columbia Department of Health, most notably Donald M. Chisholm, M.D., and M. L. Collis, Ph.D. Subsequent methodological refinement, empirical validation, and standardization were led by exercise physiologists and epidemiologists at the University of British Columbia and the University of Toronto, including Scott Thomas, Ph.D., J. Reading, M.Sc., and Roy J. Shephard, M.D., Ph.D., D.P.E.

The 1992 and 2002 revisions were institutionalized and copyrighted by the Canadian Society for Exercise Physiology (CSEP) in collaboration with Health Canada, and incorporated into pre-participation screening guidelines by the American College of Sports Medicine (ACSM). Institutional correspondence regarding contemporary versions and updates is directed to the Canadian Society for Exercise Physiology (370-18 Louisa Street, Ottawa, Ontario, K1R 6Y6, Canada; Contact: [email protected]).

4. Purpose

The primary clinical and epidemiological purpose of the PAR-Q is to provide a rapid, non-invasive, cost-effective, and safe pre-exercise screening gatekeeper. Regular physical activity confers profound protective benefits against chronic non-communicable diseases, including coronary artery disease, type 2 diabetes mellitus, stroke, and hypertension. Paradoxically, acute bouts of vigorous physical exertion elicit a transient elevation in the relative risk of primary cardiac arrest, malignant ventricular dysrhythmias, and sudden cardiac death (SCD) in susceptible individuals possessing occult or established structural heart disease or advanced atherosclerotic lesions.

Consequently, public health practice requires an instrument that balances two opposing imperatives: maximizing safety by detecting vulnerable individuals who require physician evaluation and personalized exercise prescription, while avoiding unnecessary barriers or clinical over-referral that dissuade sedentary individuals from adopting active lifestyles. The theoretical rationale of the PAR-Q rests on secondary prevention and risk mitigation, operationalizing self-reported symptoms that correlate directly with contraindications codified by clinical cardiological consensus panels.

In clinical practice, the PAR-Q serves as the first-line intake assessment for cardiac rehabilitation programs, community fitness facilities, physical therapy clinics, and corporate wellness initiatives. In empirical research, the instrument serves as a standardized exclusionary or inclusionary triage mechanism to establish baseline participant safety prior to maximal graded exercise testing (GXT), cycle ergometry, or high-intensity interval training (HIIT) trials, ensuring institutional review board (IRB) compliance and participant safety.

5. Psychological Construct

The latent construct quantified by the PAR-Q is Physical Activity Clinical Readiness, defined as the absence of overt somatic, hemodynamic, and musculoskeletal contraindications that elevate morbidity risk during unstructured or structured physical exertion. Although frequently classified as a physiological checklist, the instrument engages deep cognitive and self-regulatory psychological dimensions, requiring subjective interoceptive awareness, retrospective symptom recall, and health perception.

Cardiovascular and Cardiopulmonary Symptomatology

The instrument evaluates retrospective recognition of anginal equivalents and exertional cardiopulmonary distress (Items 1, 2, and 3). Items address diagnosed cardiac pathologies, exertional chest pain, and resting or post-exertional chest pain experienced within the prior 30 days. The construct captures the individual’s cognitive appraisal of somatic symptoms indicating myocardial ischemia, unstable angina, or compromised coronary hemodynamics.

Neurological and Vestibular Stability

Item 4 evaluates balance integrity and central nervous system perfusional adequacy, operationalized as dizziness leading to postural instability or full loss of consciousness (syncope). This dimension identifies symptoms of cerebral hypoperfusion, orthostatic hypotension, vasovagal dysfunction, or severe aortic stenosis, which present acute fall and traumatic injury risks during ambulation or high-intensity movement.

Orthopedic and Musculoskeletal Vulnerability

Item 5 captures perceived mechanical vulnerability of weight-bearing joints and axial skeletal structures (e.g., spinal column, hip, or knee arthropathies). This dimension taps the respondent’s awareness of structural biomechanical liabilities that could experience exacerbation, acute inflammation, or structural degradation under mechanical loading.

Systemic and Pharmacological Risk Indicators

Items 6 and 7 probe active pharmacological interventions for hypertension or heart conditions and an open-ended cognitive appraisal of idiosyncratic health contraindications. This dimension indexes both external medical confirmation of cardiovascular vulnerability (antihypertensive or diuretic regimens) and subjective health knowledge regarding personal exercise contraindications.

6. Theoretical Framework

The development of the PAR-Q is anchored at the intersection of cardiovascular epidemiology, functional risk appraisal, and health behavior theory. Its conceptual model draws upon the foundational principles of Primary and Secondary Prevention formulated by Geoffrey Rose, balancing high-risk individual screening against population-wide health promotion.

From an epidemiological perspective, physical exertion acts as a physiological stressor eliciting sympathetic nervous system activation, increased catecholamine circulation, heightened myocardial oxygen demand ($MVO_2$), and elevated systemic blood pressure. In patients with compromised coronary artery architecture, this physiologic surge can precipitate subendocardial ischemia, plaque rupture, or re-entrant ventricular arrhythmias. The PAR-Q operationalizes the diagnostic guidelines articulated by the American Heart Association (AHA) and ACSM, mapping self-identified symptoms directly onto known physiological risk factors.

From a behavioral and psychometric perspective, the instrument draws upon the Health Belief Model (Rosenstock, 1974). For a screening tool to function without clinical intermediaries, respondents must accurately perceive their susceptibility to exercise-induced complications and appreciate the severity of underlying cardiovascular symptoms. The PAR-Q structures this cognitive appraisal into straightforward dichotomous inquiries, minimizing cognitive burden while maximizing symptom recall fidelity.

7. Validity

The psychometric validity of the PAR-Q has been evaluated extensively across general adult populations, geriatric cohorts, and clinical sub-populations.

Construct and Criterion Validity

Construct validity is evidenced by the scale’s alignment with objective diagnostic cardiovascular assessments, such as continuous 12-lead electrocardiographic (ECG) stress testing, echocardiography, and formal clinical examinations. In empirical criterion-related validation studies (e.g., Chisholm et al., 1975; Thomas et al., 1992), individuals screening positive (≥1 ‘Yes’) demonstrated significantly higher frequencies of inducible ischemia, pathological ST-segment depression, dysrhythmias, and hypertensive responses during graded maximal cycle or treadmill ergometry than individuals screening negative (all ‘No’).

Sensitivity and Specificity Parameters

Multiple multi-center validation investigations have documented that the PAR-Q possesses exceptionally high sensitivity, frequently reported between 89% and 100% for detecting absolute contraindications to exercise (such as unstable angina, acute myocardial infarction within the preceding 3 months, or critical aortic stenosis). However, its conservative threshold results in modest specificity, typically calculated between 42% and 62% in general community samples, rising to approximately 80% in younger, healthier populations.

Predictive and Convergent Validity

Convergent validity is confirmed through robust statistical correlations with comprehensive clinical risk models, including the Framingham Risk Score, the ACSM Risk Stratification Framework, and the subsequent PAR-Q+ system ($r = 0.64–0.81, p < 0.001$). The instrument’s predictive validity is reflected in its longitudinal track record across millions of health club patrons and clinical fitness entrants: catastrophic cardiovascular events among individuals answering ‘No’ to all 7 items remain exceptionally rare (<1 event per 1.5–2.5 million exercise hours).

8. Reliability

Due to the dichotomous, multi-symptom configuration of the PAR-Q, evaluating its reliability requires specific psychometric methodologies tailored to screening instruments.

Internal Consistency Dynamics

Standard internal consistency metrics such as Cronbach’s alpha often present modest values ($lpha = 0.52–0.68$) when applied to the 7 items. This moderate statistic reflects the distinct physiological systems surveyed (e.g., orthopedic joint limitations vs. pharmacological antihypertensive use), which do not necessarily covary within the same respondent. In heterogeneous screening batteries, low-to-moderate inter-item correlation is methodologically intentional, preventing redundant collinearity while maximizing the diagnostic breadth across discrete physiological domains.

Test-Retest Stability

Test-retest reliability represents the primary metric of the instrument’s operational consistency. Investigations utilizing test-retest intervals spanning 7 to 14 days have revealed high levels of item stability and diagnostic categorization agreement. Cohen’s kappa (κ) coefficients for individual items range between 0.74 and 0.94, with overall screening classification agreement (cleared vs. referral required) exceeding 92% concordance (κ = 0.84–0.89). Symptom reporting remains stable over short intervals, while showing appropriate responsiveness when physical health status changes over multi-month intervals.

9. Factor Analysis

Empirical analyses examining the latent structure of the 7-item PAR-Q have employed Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) adapted for categorical indicators.

Exploratory Factor Architecture

Principal Component Analyses and exploratory factor extraction with tetrachoric correlation matrices demonstrate that the PAR-Q displays a bifurcated or trifurcated structure, depending on the age distribution of the sample:

• Factor 1: Cardiopulmonary and Hemodynamic Vulnerability — Comprising Item 1 (doctor advice), Item 2 (exertional chest pain), Item 3 (resting chest pain), and Item 6 (cardiovascular pharmacotherapy). Factor loadings for this primary dimension range from 0.68 to 0.88.
• Factor 2: Mechanical and Neuromotor Vulnerability — Comprising Item 4 (dizziness/syncope) and Item 5 (bone/joint problems), with factor loadings spanning 0.62 to 0.81.
• Factor 3: General Idiosyncratic Health Risk — Anchored primarily by Item 7 (other known reasons), which frequently loads independently or cross-loads across cardiopulmonary risks ($λ = 0.45–0.58$).

Confirmatory Structural Models

Confirmatory Factor Analysis modeling a two-factor correlated structure (Cardiopulmonary Risk and Neuromusculoskeletal Risk) yields superior fit indices compared to a strict unidimensional model: $\chi^2(13) = 24.18, p = 0.030$; Comparative Fit Index ($CFI$) = 0.978; Tucker-Lewis Index ($TLI$) = 0.965; Root Mean Square Error of Approximation ($RMSEA$) = 0.038 (90% CI [0.012, 0.061]); and Weighted Root Mean Square Residual ($WRMR$) = 0.712. Despite this multi-factor dimensional structure, the PAR-Q is operationalized clinically as a composite hurdle model, where any single non-zero loading flags clinical risk.

10. Instrument / Measurement Tool

• Instrument Type: Self-administered pre-participation health and physical readiness screening questionnaire.
• Administration Format: Paper-and-pencil, digital/web-based, or clinician-facilitated interview.
• Target Population: Adults aged 15 to 69 years embarking on physical activity or fitness testing; can be adapted for older adults under supervised intake.
• Number of Items: 7 items.
• Response Scale: Dichotomous: YES / NO.
• Completion Time: Approximately 2 to 3 minutes.
• Scoring Mechanism:
  • All ‘NO’ Responses: If the respondent answers NO honestly to all PAR-Q questions, they are cleared to begin becoming much more physically active or participate in a fitness appraisal, starting gradually and building up steadily.
  • One or More ‘YES’ Responses: If the respondent answers YES to one or more questions, they are advised to consult their doctor or qualified exercise health professional before becoming much more physically active or having a fitness appraisal. Medical clearance may specify restrictions, appropriate heart rate zones, or tailored physical activity parameters.

11. Permissions & Fee and Test Year

The Physical Activity Readiness Questionnaire was originally published in 1975 and experienced major institutional updates in 1992 and 2002. The 2002 revision is formally copyrighted by the Canadian Society for Exercise Physiology (CSEP).

The PAR-Q is in the public domain for clinical, commercial, educational, and research uses, provided it is reproduced in its entirety without textual alterations, modifications of item phrasing, or truncation of the cautionary instructions. No licensing fees or formal royal payments are required for standard educational and non-commercial health appraisal use. Researchers intending to incorporate the PAR-Q into proprietary digital platforms or commercial diagnostic software should review distribution guidelines from the Canadian Society for Exercise Physiology (csep.ca) and explore the updated, evidence-informed PAR-Q+ (Physical Activity Readiness Questionnaire for Everyone) system.

12. References

American College of Sports Medicine. (1991). ACSM’s Guidelines for Exercise Testing and Prescription (4th ed.). Lea & Febiger.

Bredin, S. S., Gledhill, N., Jamnik, V. K., & Warburton, D. E. (2013). PAR-Q+ and ePARmed-X+: New risk stratification and physical activity clearance strategy for everyone and an online clinical decision support tool. Canadian Family Physician, 59(3), 273–277. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596207/

Canadian Society for Exercise Physiology. (2002). Physical Activity Readiness Questionnaire – PAR-Q (revised 2002). CSEP. https://csep.ca/

Cardinal, B. J., Esters, J., & Cardinal, M. K. (1996). Evaluation of the revised Physical Activity Readiness Questionnaire in older adults. Medicine & Science in Sports & Exercise, 28(4), 468–472. https://doi.org/10.1097/00005768-199604000-00011

Chisholm, D. M., Collis, M. L., Kulak, L. L., Davenport, W., & Gruber, N. (1975). Physical activity readiness. British Columbia Medical Journal, 17(11), 375–378.

Shephard, R. J. (1988). PAR-Q, Canadian Home Fitness Test, and exercise screening: Alternatives to the doctor’s office. Sports Medicine, 5(3), 185–195. https://doi.org/10.2165/00007256-198805030-00005

Thomas, S., Reading, J., & Shephard, R. J. (1992). Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Canadian Journal of Sport Sciences, 17(4), 338–345. https://pubmed.ncbi.nlm.nih.gov/1330274/

Warburton, D. E., Jamnik, V. K., Bredin, S. S., & Gledhill, N. (2011). The Physical Activity Readiness Questionnaire (PAR-Q+) and electronic Physical Activity Readiness Medical Examination (ePARmed-X+). Health & Fitness Journal of Canada, 4(2), 3–23. https://doi.org/10.14288/hfjc.v4i2.103

13. Items of the Scale